Moore Capital Management, LP Guardant Health, Inc. Transaction History

Moore Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$48.25 - $100.49 $1.6 Million - $3.33 Million	-33,089 Reduced 59.05%	22,943 $1.52 Million
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $32.1 Million - $43.6 Million	-362,308 Reduced 86.61%	56,032 $5.6 Million
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $30.8 Million - $41.3 Million	312,319 Added 294.58%	418,340 $52.3 Million
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $1.72 Million - $2.59 Million	15,652 Added 17.32%	106,021 $13.2 Million
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $3.14 Million - $4.42 Million	-24,689 Reduced 21.46%	90,369 $13.8 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $10 Million - $13.6 Million	100,058 Added 667.05%	115,058 $14.8 Million
Q3 2020 Nov 16, 2020	SELL	$80.32 - $111.8 $803,199 - $1.12 Million	-10,000 Reduced 40.0%	15,000 $1.68 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $1.51 Million - $2.44 Million	25,000 New	25,000 $2.03 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.17B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.